Drug Profile
Research programme: melanin-concentrating hormone receptor 1 antagonists - 7TM Pharma
Alternative Names: TM30335Latest Information Update: 07 Jul 2010
Price :
$50
*
At a glance
- Originator 7TM Pharma
- Class Quinolines
- Mechanism of Action MCHR1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS disorders; Obesity
Most Recent Events
- 30 Sep 2005 Suspended - Preclinical for CNS disorders in Denmark (unspecified route)
- 30 Sep 2005 Suspended - Preclinical for Obesity in Denmark (unspecified route)
- 23 Aug 2005 Discontinued - Preclinical for Obesity in Denmark (unspecified route)